Lack of Levofloxacin and Moxyfloxacin Efficacy in Experimental Plague of Albino Mice Infected with Nalidixic Acid Resistant Pathogen (Nalr)
Abstract
The efficacy of levofloxacin and moxyfloxacin vs. the previously tested fluoroquinolones was studied on albino mice with experimental plague due to the Nalr mutants of Yersinia pestis 231 and 231 FI-. The plague microbe mutants resistant to nalidixic acid (Nalr) generated at a frequency of 10'10-10'9. The resistance to nalidixic acid was not accompanied by the strains loss of the virulence. The Nalr mutants were cross resistant to fluoroquinolones (ciprofloxacin, moxyfloxacin). The LD50 for the nontreated animals did not differ from that for the mice treated with nalidixic acid and the fluoroquinolones (when the animals were infected with Nalr mutants). The results showed that the criteria of the plague microbe susceptibility/resistance to fluoroquinolones should be revised.
About the Authors
I. V. Ryzhko
Rostov-on-Don Research Plague Institute
Russian Federation
Russian Federation
A. V. Trishina
Rostov-on-Don Research Plague Institute
Russian Federation
Russian Federation
L. M. Verkina
Rostov-on-Don Research Plague Institute
Russian Federation
Russian Federation
References
1. Рыжко И. В., Цураева Р. И., Анисимов Б. И., Тришина А. В. Эффективность левофлоксацина, ломефлоксацина и моксифлоксацина в сравнении с другими фторхинолонами при экспериментальной чуме белых мышей, вызванной FI+ FI- штаммами возбудителя. Антибиотики и химиотер 2009; 54: 5-6: 37-47.
2. Kuberski T., Robinson L., Schurgin A. A case ofplague successfully treated with ciprofloxacin and sympathetic blockade for treatment of gangrene. Clin Infect Dis 2003; 36: 4: 521-523.
3. Perlman D. C, Primas R., Raucher B. et al. Imported plague New York City, 2002. MMWR Morb Mortal Wkly Rep 2003; 52: 31: 725-728.
4. Определение чувствительности микроорганизмов к антибактериальным препаратам: Методические указания МУК 4.2.1890-04. М.: 2004; 91.
5. Страчунский Л. С., Белоусова Ю. Б., Козлова С. Н. Практическое руководство по антиинфекционной химиотерапии. М.: Боргес, 2002; 384.
6. Яковлев В. П., Яковлев С. В. Рациональная антимикробная фармакотерапия. Руководство для практикующих врачей. М.: Литература, 2003; 1008.
7. Белобородова Н. В., Попов Д. А., Бачинская Е. Н. и др. Клинико-микробиологическая эффективность моксифлоксацина при лечении инфекционного эндокардита. Антибиотики и химиотер 2006; 51: 9-10: 33-39.
8. Ашмарин И. П., Воробьев А. А. Статистические методы в микробиологических исследованиях. Л.: Ленмедгиз, 1962; 177.
9. Paget J. E., Barnes Y. M. Toxicity tests // Evaluation of drug activities pharmacometris. London, 1964; 1: 135-167.
10. Galimand M., Guiyoule A., Gerbaud G. et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. The New Engl J Med 1997; 337: 10: 677-680.
Review
For citations:
Ryzhko I.V., Trishina A.V., Verkina L.M. Lack of Levofloxacin and Moxyfloxacin Efficacy in Experimental Plague of Albino Mice Infected with Nalidixic Acid Resistant Pathogen (Nalr). Antibiot Khimioter = Antibiotics and Chemotherapy. 2010;55(11-12):22-24. (In Russ.)
Views:
312
Email this article 